Share >  
Share
Share on Tumblr

Glenmark Generics Ltd

News »

   latest by relevance
Ind-Swift launches Atorvastatin Tablets in UK
May 16, 2012 at 17:55 | Source: Moneycontrol.com
Ind-Swift added another feather in its cap by launching generic formulations of the Worlds best selling drug Atorvastatin in UK in collaboration with Wockhardt UK Ltd. on the first day of its patent expiry.
Lupin launches Generic Combivir tablets
May 16, 2012 at 12:41 | Source: Moneycontrol.com
Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. has received final approval for its Lamivudine and Zidovudine Tablets, 150 mg/300 mg. from the United States Food and Drugs Administration (FDA). Lupin has already commenced shipping the product.
Glenmark gets tentative US nod for migraine treatment drug
May 16, 2012 at 12:24 | Source: Moneycontrol.com
Glenmark Pharma's US generics arm has received tentative approval from US Food and Drugs Administration (FDA) for Zolmitriptan orally disintegrating tablets, its copy of AstraZeneca's ZomigZMT tablets.
Glenmark sees 22-25% sales growth, no acquisitions in FY13
May 09, 2012 at 12:08 | Source: Moneycontrol.com
After a strong growth in 2011-12, Glenmark Pharmaceuticals expects to continue strong growth momentum this year too. It expects sales will rise 22-25% (excluding licensing income), helped by new drug launches in the US market and strong growth in most other regions.
Launches in FY13 to boost growth in Indian market: Glenmark
May 09, 2012 at 11:42 | Source: CNBC-TV18
Aided by malarone and cutivate generic, the US business of Glenmark Pharma saw recovery in the fourth quarter of FY12. In an interview with CNBC-TV18, Glenn Saldanha, MD & CEO of Glenmark said, the company expects its domestic market to outperform industry in FY13.
Glenmark gets US FDA nod for generic antiepileptic drug
May 07, 2012 at 14:27 | Source: Moneycontrol.com
Glenmark Phama's arm Glenmark Generics USA has received US Food and Drugs Administration Approval for its abbreviated new drug approval (ANDA) for Lamotrigine Tablets in various strengths.

Videos »
Launches in FY13 to boost growth in Indian market: Glenmark
Profit down 35%, but topline at record Rs 1055 cr: Glenmark
Glenmark settles patent litigation with Daiichi, Genzyme
See Nifty in range of 5450-5600 for few days: Deven Choksey
Glenmark confident of US growth despite Tarka issue
more »

Photos »

  /  
News across the web »
Glenmark Generic gets US nod for anti-epileptic drugLamotrigine, which is also indicated for bipolar disorders, had sales of $62 million in calendar 2011
Glenmark Generics Inc, USA, a subsidiary of Glenmark Generics Ltd, has been granted final abbreviated new drug approval (ANDA) from the US Food and Drug Administration for its Lamotrigine 25, 100, 150...
May 08, 2012 at 06:37 | Source: Business Standard
Glenmark Generics receives USFDA nod for Norgestimate and Ethinyl Estradiol Tablets
Glenmark Generics Inc USA, a subsidiary of Glenmark Generics Ltd has announced they have been granted final approval for their abbreviated new drug application (ANDA) by the United States Food and Dr...
Apr 09, 2012 at 11:07 | Source: India Infoline
Glenmark Generics gets ANDA approval for Desogestrel & Ethinyl Estradiol Tablets
Glenmark Generics Inc., USA, a subsidiary of Glenmark Generics Ltd, has announced they have been granted final approval for their abbreviated new drug application (ANDA) by the United States Food and...
Apr 03, 2012 at 11:02 | Source: India Infoline
Glenmark recalls select lot of oral contraceptive in US
Tweet NEW DELHI: Glenmark Pharmaceuticals today said it has issued a voluntary nationwide recall in the US for seven lots of its oral contraceptive Norgestimate and Ethinyl Estradiol tablets due to a ...
Feb 26, 2012 at 06:07 | Source: Economic Times
Glenmark recalls select lot of oral contraceptive in US due to a packaging error
Glenmark Pharmaceuticals on Saturday said it has issued a voluntary nationwide recall in the US for seven lots of its oral contraceptive Norgestimate and Ethinyl Estradiol tablets due to a packaging ...
Feb 26, 2012 at 04:42 | Source: Business Today
more »
Interact & exchange stock tips & market info »

Web Messenger

Platinum Member

108212 Followers

Glenmark  

Source:India Infoline - Glenmark Generics Inc USA, a subsidiary of

2.02 PM Apr 9th

Web Messenger

Platinum Member

108212 Followers

Glenmark  

Source:India Infoline - Glenmark Generics Inc., USA, a subsidiary of ...

1.30 PM Apr 3rd

NEWS786

Platinum Member

183 Followers

Glenmark  

it clarified that it would not pose any immediate health risks. The...

8.53 PM Feb 28th

Related News »
Glenmark Gets USFDA Tentative Nod For Zolmitriptan Orally Disintegrating Tablets
(RTTNews) - Glenmark Pharmaceuticals Ltd. said its US subsidiary Glenmark Generics Inc. has obtained tentative approval from US FDA for Zolmitriptan orally disintegrating tablets, its generic version of AstraZeneca's Zomig-ZMT tablets. The tentative ...
May 16, 2012 at 06:56 | Source: RTT News
Glenmark Pharmaceuticals Ltd - Hem Securities
464.03 crore for the corresponding previous quarter, registering growth of 28%. Glenmark, through its arm Glenmark Generics, launched 12 products in the US market in FY12, most of which were in the dermatology and oral contraceptive segments.
May 25, 2012 at 15:13 | Source: equitybulls.com
Glenmark Generics receives tentative U.S. FDA approval for zolmitriptan orally disintegrating tablets
Glenmark Generics Inc. USA the United States subsidiary of Glenmark ... The Glenmark Pharmaceuticals Ltd stock was trading at Rs.356.25, down by Rs.9.10 or 2.49%. The stock hit an intraday high of Rs.369.70 and low of Rs.352.65.
May 16, 2012 at 07:17 | Source: equitybulls.com
Glenmark Generics gets US FDA tentative nod for zolmitriptan tablets
has granted tentative approval for Glenmark Generics Inc's (GGI), a US based subsidiary of Glenmark Pharmaceuticals Ltd, zolmitriptan orally disintegrating tablets, the generic version of AstraZeneca's Zomig-ZMT tablets. The tentative approval is for the 2 ...
May 16, 2012 at 07:46 | Source: pharmabiz.com
Domestic pharma market still on strong growth trajectory
The outperformers have been Cadila Healthcare Ltd, Glenmark, GlaxoSmithKline and Pfizer ... The CVS segment has witnessed strong traction, driven by branded generics. It has leadership in vaccines and hormones with 19% and 20% market share, respectively.
May 23, 2012 at 17:17 | Source: Livemint.com

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window